BioCryst (BCRX) Director Vincent Milano Receives Award 1,159 Shares

What Happened Vincent Milano, a director of BioCryst Pharmaceuticals (BCRX), was issued 1,159 shares on 2026-08-31 as an award/compensation. The filing lists a per-share valuation of $9.70, putting the grant at approximately $11,242. This was an issuance (award) of stock rather than an open-market purchase or sale.

Key Details

• Transaction date and terms: 2026-08-31 — 1,159 shares issued at $9.70 per share (total ~$11,242). Transaction code: A (award/grant/acquisition).
• Reason / footnote: Shares issued to Milano in lieu of 50% of the quarterly cash Board Chair retainer of $22,500.
• Filing: Form 4 filed 2026-09-02 (appears timely based on the transaction date).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• No indication of a 10b5-1 plan, option exercise, sale, gift, or tax-withholding reported in the provided data.

Context This issuance is a routine director compensation event — directors commonly receive equity in lieu of cash retainers. Such awards reflect compensation policy rather than a direct buy/sell decision by the insider and should not be interpreted as a market sentiment trade.